갑상선기능항진증의 진단 및 치료- 대한갑상선학회 합의안

참고문헌 (67)

1. Cho BY, "Clinical thyroidology" (2010), Korea Medical Book Publisher
2. Gozu HI, "Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism", Mol Cell Endocrinol, 322(1-2), pp.125~134 (2010)
3. Bahn Chair RS, "Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists", Thyroid, 21(6), pp.593~646 (2011)
4. Cho BY, "Current trends in the diagnosis and treatment of Graves' disease in Korea", Endocrinol Metab, 7(3), pp.216~227 (1992)
5. Wartofsky L, "Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States", Thyroid, 1(2), pp.129~135 (1991)
6. Boelaert K, "Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study", J Clin Endocrinol Metab, 95(6), pp.2715~2726 (2010)
7. Klein I, "Thyroid disease and the heart", Circulation, 116(15), pp.1725~1735 (2007)
8. European Heart Rhythm A, "ACC", AHA, American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation), pp.J Am Coll Cardiol, 2006[DOI]
9. Socin HV, "The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients", Eur J Endocrinol, 148(4), pp.433~442 (2003)
10. Brucker-Davis F, "Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study", Ann Intern Med, 123(8), pp.572~583 (1995)
11. Shigemasa C, "Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels", J Clin Endocrinol Metab, 65(2), pp.359~363 (1987)
12. Pedersen IB, "TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays", Clin Endocrinol (Oxf), 55(3), pp.381~390 (2001)
13. Bogazzi F, "Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease?", Nat Clin Pract Endocrinol Metab, 4(2), pp.70~71 (2008)
14. Trzepacz PT, "Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms", Am J Med, 87(5), pp.558~561 (1989)
15. Klein I, "Treatment of hyperthyroid disease", Ann Intern Med, 121(4), pp.281~288 (1994)
16. Abraham-Nordling M, "Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery", Thyroid, 15(11), pp.1279~1286 (2005)
17. Kuy S, "Outcomes following thyroid and parathyroid surgery in pregnant women", Arch Surg, 144(5), pp.399~406 (2009)
18. Cooper DS, "Antithyroid drugs", N Engl J Med, 352(9), pp.905~917 (2005)
19. Cooper DS, "Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance", Ann Intern Med, 102(3), pp.328~331 (1985)
20. Cooper DS, "Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies", J Clin Endocrinol Metab, 88(8), pp.3474~3481 (2003)
21. Abraham P, "A systematic review of drug therapy for Graves' hyperthyroidism", Eur J Endocrinol, 153(4), pp.489~498 (2005)
22. Andersohn F, "Systematic review: agranulocytosis induced by nonchemotherapy drugs", Ann Intern Med, 146(9), pp.657~665 (2007)
23. Meyer-Gessner M, "Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature", J Endocrinol Invest, 17(1), pp.29~36 (1994)
24. Ruiz JK, "Fulminant hepatic failure associated with propylthiouracil", Ann Pharmacother, 37(2), pp.224~228 (2003)
25. Bahn RS, "The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration", Thyroid, 19(7), pp.673~674 (2009)
27. Vilchez FJ, "Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole", Ann Pharmacother, 40(11), pp.2059~2063 (2006)
28. Woeber KA, "Methimazole-induced hepatotoxicity", Endocr Pract, 8(3), pp.222~224
29. 박근, "임신 초기에 Methimazole 노출 후 발생한 선천성 피부 형성 부전증 1예", 대한피부과학회지, 44(5), pp.642~644 (2006), 대한피부과학회
30. 김묘징, "임신 중 Methimazole을 복용한 산모의 자녀에서 발생한 선천성 피부 무형성증 1례", Annals of Pediatirc Endocrinology & Metabolism, 13(1), pp.100~103 (2008), 대한소아내분비학회
31. Wolf D, "Antenatal carbimazole and choanal atresia: a new embryopathy", Arch Otolaryngol Head Neck Surg, 132(9), pp.1009~1011 (2006)
32. Clark SM, "Pharmacokinetics and pharmacotherapy of thionamides in pregnancy", Ther Drug Monit, 28(4), pp.477~483 (2006)
33. Mazza E, "Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study", J Endocrinol Invest, 31(10), pp.866~872 (2008)
34. The Japan Thyroid Association, "Guideline for the treatment of Graves' disease with antithyroid drug in Japan" (2006), Nankodo Co
35. Kimball LE, "Does smoking increase relapse rates in Graves' disease?", J Endocrinol Invest, 25(2), pp.152~157 (2002)
36. Allahabadia A, "Age and gender predict the outcome of treatment for Graves' hyperthyroidism", J Clin Endocrinol Metab, 85(3), pp.1038~1042 (2000)
37. Nedrebo BG, "Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease", Eur J Endocrinol, 147(5), pp.583~589 (2002)
38. Bolanos F, "Remission of Graves' hyperthyroidism treated with methimazole", Rev Invest Clin, 54(4), pp.307~310 (2002)
39. Orgiazzi J, "Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease", Thyroid, 12(10), pp.849~853 (2002)
40. Glinoer D, "Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study", Eur J Endocrinol, 144(5), pp.475~483 (2001)
41. Takasu N, "Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment", Thyroid, 10(10), pp.891~896 (2000)
42. McDermott MT, "Radioiodine-induced thyroid storm. Case report and literature review", Am J Med, 75(2), pp.353~359 (1983)
43. Walter MA, "Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials", BMJ, 334(7592), pp.514~ (2007)
44. Delit C, "Thyrocardiac disease and its management with radioactive iodine I-131", JAMA, 176, pp.262~267 (1961)
45. Burch HB, "The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease", J Clin Endocrinol Metab, 86(7), pp.3016~3021 (2001)
46. Andrade VA, "Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism", J Clin Endocrinol Metab, 84(11), pp.4012~4016 (1999)
47. Klein I, "Endocrine disorders and cardiovascular disease, In Braunwald's heart disease: a textbook of cardiovascular medicine", pp.2033~2047 (2008), Saunders Elsevier
48. Santos RB, "Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease", Thyroid, 14(7), pp.525~530 (2004)
49. Peters H, "Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study", Eur J Clin Invest, 25(3), pp.186~193 (1995)
50. Fisher WD, "Congenital hypothyroidism in infant following maternal I-131 therapy with a review of hazards of environmental radioisotope contamination", J Pediatr, 62, pp.132~146 (1963)
51. Berg GE, "Radioiodine treatment of hyperthyroidism in a pregnant women", J Nucl Med, 39(2), pp.357~361 (1998)
52. Uy HL, "Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease", Am J Med, 99(2), pp.173~179 (1995)
53. Alexander EK, "High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease", J Clin Endocrinol Metab, 87(3), pp.1073~1077 (2002)
54. Erbil Y, "Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease", J Clin Endocrinol Metab, 92(6), pp.2182~2189 (2007)
55. Ansaldo GL, "Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter", J Am Coll Surg, 191(6), pp.607~612 (2000)
56. Baeza A, "Rapid preoperative preparation in hyperthyroidism", Clin Endocrinol (Oxf), 35(5), pp.439~442 (1991)
57. Palit TK, "The efficacy of thyroidectomy for Graves' disease: A meta-analysis", J Surg Res, 90(2), pp.161~165 (2000)
58. Sosa JA, "The importance of surgeon experience for clinical and economic outcomes from thyroidectomy", Ann Surg, 228(3), pp.320~330 (1998)
59. Sosa JA, "A population-based study of outcomes from thyroidectomy in aging Americans: at what cost?", J Am Coll Surg, 206(3), pp.1097~1105 (2008)
60. Jumaily JS, "Prediction of hypocalcemia after using 1- to 6-hour postoperative parathyroid hormone and calcium levels: an analysis of pooled individual patient data from 3 observational studies", Head Neck, 32(4), pp.427~434 (2010)
61. McLeod IK, "The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy", Thyroid, 16(3), pp.259~265 (2006)
63. Noordzij JP, "Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies", J Am Coll Surg, 205(6), pp.748~754 (2007)
64. Cote V, "Cost savings associated with post-thyroidectomy parathyroid hormone levels", Otolaryngol Head Neck Surg, 138(2), pp.204~208 (2008)
65. Bellantone R, "Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy?", Surgery, 132(6), pp.1109~ (2002)
66. Wilson RB, "Hypomagnesemia and hypocalcemia after thyroidectomy: prospective study", World J Surg, 24(6), pp.722~726 (2000)
67. Roh JL, "Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy", Am J Surg, 192(5), pp.675~678 (2006)

관련 논문AI추천